Therapeutic plasma exchange as a treatment for Central Pontine Myelinolysis in a 41-year-Old male with Chronic Renal Insufficiency: A case report
- Author:
Guillermo III Lacuesta Manalo
1
;
Aurelio Pantaleon S Reyes
2
;
Jane Wendolyn Wong Lu-Reyes
1
;
Catherine Matnao Carabbacan
1
;
Joice Bumanglag Dela Cruz
1
;
Marie Joyce Urnos Santos
1
;
Donaryn Villa Pasamonte
1
;
Sheryll Juan Pascual
1
;
Deanna Dauz Quilala
1
Author Information
- Publication Type:Case Reports
- Keywords: Therapeutic plasma exchange
- MeSH: Myelinolysis, Central Pontine; Renal Insufficiency, Chronic
- From: Philippine Journal of Internal Medicine 2022;60(3):215-218
- CountryPhilippines
- Language:English
- Abstract: Therapeutic plasma exchange (TPE) has been reported as a possible treatment for osmotic demyelination syndrome – central pontine myelinolysis (ODS-CPM), a degeneration of myelin within the central nervous system related to rapid hyponatremia correction, which though uncommon, has significant morbidity, and has no established specific treatment. We present our experience with a 41-year-old male with chronic kidney disease, maintained on steroids, who presented with lethargy and behavioral changes. Initial metabolic panel showed severe hyponatremia (Na 109 mEq/L). Despite cautious sodium correction, the patient’s sensorium decreased further and was intubated. Involuntary movements of the left face and arm were later seen. T2/FLAIR hyperintensities in the brainstem and thalami affirmed the diagnosis of ODS. A total of nine cycles (one cycle every two to three days) of TPE were completed. The patient was discharged with improved sensorium, from E2VxM4 to E4VxM6, and with no indication for hemodialysis due to improved creatinine. One year later, the patient has no remaining neurologic deficits. Our experience supports other case reports that TPE is a viable therapy for ODS-CPM.
- Full text:10 - Therapeutic.pdf
